Top-Rated StocksTop-RatedNYSE:EVH Evolent Health (EVH) Stock Price, News & Analysis $7.69 +0.48 (+6.66%) Closing price 03:59 PM EasternExtended Trading$7.48 -0.21 (-2.73%) As of 06:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Evolent Health Stock (NYSE:EVH) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Evolent Health alerts:Sign Up Key Stats Today's Range$7.33▼$7.7050-Day Range$7.19▼$10.7752-Week Range$7.06▼$33.63Volume1.73 million shsAverage Volume2.42 million shsMarket Capitalization$902.81 millionP/E RatioN/ADividend YieldN/APrice Target$17.79Consensus RatingBuy Company OverviewEvolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.Read More… Evolent Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks58th Percentile Overall ScoreEVH MarketRank™: Evolent Health scored higher than 58% of companies evaluated by MarketBeat, and ranked 344th out of 646 stocks in the computer and technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.5 / 5Analyst RatingBuy Consensus RatingEvolent Health has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 12 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageEvolent Health has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Evolent Health's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for Evolent Health are expected to decrease in the coming year, from $0.08 to ($0.29) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Evolent Health is -9.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Evolent Health is -9.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioEvolent Health has a P/B Ratio of 0.82. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Evolent Health's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted14.27% of the outstanding shares of Evolent Health have been sold short.Short Interest Ratio / Days to CoverEvolent Health has a short interest ratio ("days to cover") of 6.5.Change versus previous monthShort interest in Evolent Health has recently increased by 4.10%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldEvolent Health does not currently pay a dividend.Dividend GrowthEvolent Health does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted14.27% of the outstanding shares of Evolent Health have been sold short.Short Interest Ratio / Days to CoverEvolent Health has a short interest ratio ("days to cover") of 6.5.Change versus previous monthShort interest in Evolent Health has recently increased by 4.10%, indicating that investor sentiment is decreasing. News and Social Media3.0 / 5News Sentiment1.44 News SentimentEvolent Health has a news sentiment score of 1.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.85 average news sentiment score of Computer and Technology companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Evolent Health this week, compared to 6 articles on an average week.Search InterestOnly 2 people have searched for EVH on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows3 people have added Evolent Health to their MarketBeat watchlist in the last 30 days. Company Ownership1.7 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, Evolent Health insiders have bought more of their company's stock than they have sold. Specifically, they have bought $666,315.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 1.60% of the stock of Evolent Health is held by insiders.Read more about Evolent Health's insider trading history. Receive EVH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Evolent Health and its competitors with MarketBeat's FREE daily newsletter. Email Address EVH Stock News HeadlinesEvolent Health’s SWOT analysis: value-based care provider faces challenges, opportunitiesMay 27 at 1:28 AM | investing.comReflecting On Healthcare Technology for Providers Stocks’ Q1 Earnings: Evolent Health (NYSE:EVH)May 23, 2025 | msn.comBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.May 27, 2025 | Golden Portfolio (Ad)Expert Outlook: Evolent Health Through The Eyes Of 9 AnalystsMay 9, 2025 | benzinga.comEvolent Health, Inc. (EVH) Q1 2025 Earnings Call TranscriptMay 9, 2025 | seekingalpha.comEvolent Health, Inc. 2025 Q1 - Results - Earnings Call PresentationMay 9, 2025 | seekingalpha.comEvolent Health, Inc.: Evolent Announces First Quarter 2025 ResultsMay 9, 2025 | finanznachrichten.deEvolent Health (NYSE:EVH) Posts Better-Than-Expected Sales In Q1, Full-Year Outlook Slightly Exceeds ExpectationsMay 8, 2025 | msn.comSee More Headlines EVH Stock Analysis - Frequently Asked Questions How have EVH shares performed this year? Evolent Health's stock was trading at $11.25 at the start of the year. Since then, EVH shares have decreased by 31.6% and is now trading at $7.69. View the best growth stocks for 2025 here. How were Evolent Health's earnings last quarter? Evolent Health, Inc. (NYSE:EVH) issued its quarterly earnings data on Thursday, May, 8th. The technology company reported $0.06 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.08 by $0.02. The company's revenue for the quarter was down 24.4% compared to the same quarter last year. Read the conference call transcript. When did Evolent Health IPO? Evolent Health (EVH) raised $150 million in an initial public offering on Friday, June 5th 2015. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan and Goldman Sachs served as the underwriters for the IPO and Wells Fargo Securities, William Blair, SunTrust Robinson Humphrey and Leerink Partners were co-managers. Who are Evolent Health's major shareholders? Evolent Health's top institutional investors include Vanguard Group Inc. (9.38%), Eventide Asset Management LLC (5.21%), Engaged Capital LLC (4.44%) and Goldman Sachs Group Inc. (2.43%). Insiders that own company stock include Frank J Williams, Seth Blackley, Daniel Joseph Mccarthy, John Paul Johnson, Jonathan Weinberg, Diane Holder, Emily Ann Rafferty, Cheryl Scott, Mary Bridget Duffy and Brendan B Springstubb. View institutional ownership trends. How do I buy shares of Evolent Health? Shares of EVH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Evolent Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Evolent Health investors own include Humana (HUM), American Water Works (AWK), Voyager Therapeutics (VYGR), Waste Connections (WCN), The RMR Group (RMR), DiamondRock Hospitality (DRH) and Southern First Bancshares (SFST). Company Calendar Last Earnings5/08/2025Today5/27/2025Next Earnings (Estimated)8/14/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorComputer and Technology Industry Management services Sub-IndustryBusiness Services Current SymbolNYSE:EVH CIK1628908 Webwww.evolenthealth.com Phone(571) 389-6000Fax571-389-6001Employees5,100Year FoundedN/APrice Target and Rating Average Stock Price Target$17.79 High Stock Price Target$35.00 Low Stock Price Target$12.00 Potential Upside/Downside+135.4%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage14 Analysts Profitability EPS (Most Recent Fiscal Year)($1.23) Trailing P/E RatioN/A Forward P/E Ratio94.44 P/E GrowthN/ANet Income$-113,040,000.00 Net Margins-2.41% Pretax Margin-3.54% Return on Equity5.73% Return on Assets2.36% Debt Debt-to-Equity Ratio0.58 Current Ratio1.04 Quick Ratio1.04 Sales & Book Value Annual Sales$2.40 billion Price / Sales0.37 Cash Flow$1.26 per share Price / Cash Flow6.00 Book Value$9.38 per share Price / Book0.81Miscellaneous Outstanding Shares117,400,000Free Float114,699,000Market Cap$886.96 million OptionableOptionable Beta1.04 Social Links Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report This page (NYSE:EVH) was last updated on 5/27/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evolent Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evolent Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.